Vytorin Takes Low Road To Higher Ground: Lower LDL Is Key To Growth

Schering-Plough sees positioning Vytorin as the preferred cholesterol therapy for achieving lower LDL levels as the key to future growth

More from Archive

More from Pink Sheet